Arvinas and Pfizer Announce PROTAC® Protein Degrader ARV-471 Continues to Demonstrate Encouraging Clinical Benefit Rate in Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer
Go back to Arvinas and Pfizer Announce PROTAC® Protein Degrader ARV-471 Continues to Demonstrate Encouraging Clinical Benefit Rate in Patients with Locally Advanced or Metastatic ER+/HER2- Breast Cancer| (NASDAQ: ARVN) | Delayed: 7.64 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.64 | 52 Week High | $ | |||
| Open | $7.64 | 52 Week Low | $ | |||
| Day High | $7.64 | P/E | N/A | |||
| Day Low | $7.64 | EPS | $ | |||
| Volume | 343 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.28 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.28 | 52 Week High | $37.39 | |||
| Open | $28.28 | 52 Week Low | $28.25 | |||
| Day High | $28.28 | P/E | 17.14 | |||
| Day Low | $28.28 | EPS | $1.65 | |||
| Volume | 68,977 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 28.28 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $28.28 | 52 Week High | $37.39 | |||
| Open | $28.28 | 52 Week Low | $28.25 | |||
| Day High | $28.28 | P/E | 17.14 | |||
| Day Low | $28.28 | EPS | $1.65 | |||
| Volume | 68,977 | |||||



